Get startedLog in
    Picture of Avidity Biosciences logo

    RNA — Avidity Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapNeutral
    All News

    Novartis nears $70-plus per share deal to acquire Avidity Biosciences, Bloomberg News reports

    Picture of Avidity Biosciences logoAvidity Biosciences
    26/10/2025 15:06
    Oct 26 (Reuters) - Swiss drugmaker Novartis AG NOVN.S is close to acquiring U.S. biotech Avidity Biosciences RNA.O for over $70 per share, Bloomberg News reported on Sunday, citing a person familiar with the matter.

Reuters could not immediately confirm the report.

 (Reporting by Dheeraj Kumar in Bengaluru; Editing by Aidan Lewis)

 ((Dheeraj.Kumar@thomsonreuters.com;))

    Recent news on Avidity Biosciences

    See all news